China's first domestically made phaco-vitrectomy machine wins investor recognition as Rhino Health closes new funding round | Dalton Venture Family
Recently, **Dalton Venture portfolio company Rhino Health, a developer of high-end ophthalmic surgical equipment, has completed a nearly RMB 100 million Series B+ funding round**. The round was led by IN Capital, with Zhuhai Technology Industry Group participating. The proceeds will be used primarily for regulatory registration of Rhino Health's innovative ophthalmic products, overseas expansion of existing products, and domestic commercialization efforts.









